{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T13:40:52Z","timestamp":1773063652812,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T00:00:00Z","timestamp":1576627200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T00:00:00Z","timestamp":1576627200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s10067-019-04888-5","type":"journal-article","created":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T09:04:05Z","timestamp":1576659845000},"page":"1347-1355","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Insights into the pathogenesis of catastrophic antiphospholipid syndrome. A case report of relapsing catastrophic antiphospholipid syndrome and review of the literature on ischemic colitis"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1391-9828","authenticated-orcid":false,"given":"Amelia","family":"Ruffatti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Calligaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmelo S.","family":"Lacognata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"D\u2019Odorico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Colpo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"Cardin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiorella","family":"Calabrese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,18]]},"reference":[{"key":"4888_CR1","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1002\/art.10187","volume":"46","author":"R Cervera","year":"2002","unstructured":"Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT, Jacobsen S, Lakos G, Tincani A, Kontopoulou-Griva I, Galeazzi M, Meroni PL, Derksen RH, de Groot PG, Gromnica-Ihle E, Baleva M, Mosca M, Bombardieri S, Houssiau F, Gris JC, Qu\u00e9r\u00e9 I, Hachulla E, Vasconcelos C, Roch B, Fern\u00e1ndez-Nebro A, Boffa MC, Hughes GR, Ingelmo M, Euro-Phospholipid Project Group (2002) Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 46:1019\u20131027","journal-title":"Arthritis Rheum"},{"key":"4888_CR2","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1191\/0961203303lu394oa","volume":"12","author":"RA Asherson","year":"2003","unstructured":"Asherson RA, Cervera R, de Groot PG, Erkan D, Boffa MC, Piette JC, Khamashta MA, Shoenfeld Y, Catastrophic Antiphospholipid Syndrome Registry Project Group (2003) Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus 12:530\u2013534","journal-title":"Lupus"},{"key":"4888_CR3","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1177\/0961203309361353","volume":"19","author":"R Cervera","year":"2010","unstructured":"Cervera R (2010) Catastrophic antiphospholipid syndrome (CAPS): update from the CAPS registry. Lupus 19:412\u2013418","journal-title":"Lupus"},{"key":"4888_CR4","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.autrev.2016.09.010","volume":"15","author":"I Rodr\u00edguez-Pint\u00f3","year":"2016","unstructured":"Rodr\u00edguez-Pint\u00f3 I, Moitinho M, Santacreu I, Shoenfeld Y, Erkan D, Espinosa G, Cervera R, CAPS Registry Project Group (European Forum on Antiphospholipid Antibodies) (2016) Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of 500 patients from the international CAPS registry. Autoimmun Rev 15:1120\u20131124","journal-title":"Autoimmun Rev"},{"key":"4888_CR5","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.berh.2016.07.004","volume":"30","author":"I Rodriguez-Pint\u00f3","year":"2016","unstructured":"Rodriguez-Pint\u00f3 I, Espinosa G, Cervera R (2016) Catastrophic antiphospholipid syndrome: The current management approach. Best Pract Res Clin Rheumatol 30:239\u2013249","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"4888_CR6","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s12016-008-8107-9","volume":"36","author":"S Bucciarelli","year":"2009","unstructured":"Bucciarelli S, Erkan D, Espinosa G, Cervera R (2009) Catastrophic antiphospholipid syndrome: treatment, prognosis, and the risk of relapse. Clin Rev Allergy Immunol 36:80\u201384","journal-title":"Clin Rev Allergy Immunol"},{"key":"4888_CR7","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.semarthrit.2012.05.005","volume":"42","author":"G Espinosa","year":"2013","unstructured":"Espinosa G, Rodr\u00edguez-Pint\u00f3 I, Gomez-Puerta JA, Pons-Estel G, Cervera R, Catastrophic Antiphospholipid Syndrome (Caps) Registry Project Group (European Forum on Antiphospholipid Antibodies) (2013) Relapsing catastrophic antiphospholipid syndrome potential role of microangiopathic hemolytic anemia in disease relapses. Semin Arthritis Rheum 42:417\u2013423","journal-title":"Semin Arthritis Rheum"},{"key":"4888_CR8","doi-asserted-by":"crossref","unstructured":"American Gastroenterological Association Medical Position Statement: guidelines on intestinal ischemia (2000) Gastroenterology 118:951\u2013953","DOI":"10.1016\/S0016-5085(00)70182-X"},{"key":"4888_CR9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1053\/bega.2001.0265","volume":"16","author":"PH MacDonald","year":"2002","unstructured":"MacDonald PH (2002) Ischaemic colitis. Best Pract Res Clin Gastroenterol 16:51\u201361","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"4888_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fsurg.2017.00047","volume":"4","author":"EP Misiakos","year":"2017","unstructured":"Misiakos EP, Tsapralis D, Karatzas T, Lidoriki I, Schizas D, Sfyroeras GS, Moulakakis KG, Konstantos C, Machairas A (2017) Advents in the diagnosis and management of ischemic colitis. Front Surg 4:47","journal-title":"Front Surg"},{"key":"4888_CR11","doi-asserted-by":"publisher","first-page":"848","DOI":"10.3109\/00365521.2015.1010568","volume":"50","author":"AG Tsimperidis","year":"2015","unstructured":"Tsimperidis AG, Kapsoritakis AN, Linardou IA, Psychos AK, Papageorgiou AA, Vamvakopoulos NC, Kyriakou DS, Potamianos SP (2015) The role of hypercoagulability in ischemic colitis. Scand J Gastroenterol 50:848\u2013855","journal-title":"Scand J Gastroenterol"},{"key":"4888_CR12","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/j.1365-2036.2007.03250.x","volume":"25","author":"DC Suh","year":"2007","unstructured":"Suh DC, Kahler KH, Choi IS, Shin H, Kralstein J, Shetzline M (2007) Patients with irritable bowel syndrome or constipation have an increased risk for ischaemic colitis. Aliment Pharmacol Ther 25:681\u2013692","journal-title":"Aliment Pharmacol Ther"},{"key":"4888_CR13","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00384-011-1301-x","volume":"27","author":"S O\u2019Neill","year":"2012","unstructured":"O\u2019Neill S, Elder K, Harrison SJ, Yalamarthi S (2012) Predictors of severity in ischaemic colitis. Int J Color Dis 27:187\u2013191","journal-title":"Int J Color Dis"},{"key":"4888_CR14","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/j.1463-1318.2010.02272.x","volume":"13","author":"R Diaz Nieto","year":"2011","unstructured":"Diaz Nieto R, Varcada M, Ogunbiyi OA, Winslet MC (2011) Systematic review on the treatment of ischaemic colitis. Color Dis 13:744\u2013747","journal-title":"Color Dis"},{"key":"4888_CR15","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1002\/art.22018","volume":"54","author":"S Bucciarelli","year":"2006","unstructured":"Bucciarelli S, Espinosa G, Cervera R, Erkan D, G\u00f3mez-Puerta JA, Ramos-Casals M, Font J, Asherson RA, European Forum on Antiphospholipid Antibodies (2006) Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients. Arthritis Rheum 54:2568\u20132576","journal-title":"Arthritis Rheum"},{"key":"4888_CR16","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jaut.2018.07.001","volume":"93","author":"A Ruffatti","year":"2018","unstructured":"Ruffatti A, De Silvestro G, Marson P, Tonello M, Calligaro A, Favaro M, Del Ross T, Hoxha A, Mattia E, Pengo V (2018) Catastrophic antiphospholipid syndrome: lessons from 14 cases successfully treated in a single center. A narrative report. J Autoimmun 93:124\u2013130","journal-title":"J Autoimmun"},{"key":"4888_CR17","first-page":"508","volume":"19","author":"RA Asherson","year":"1992","unstructured":"Asherson RA (1992) The catastrophic antiphospholipid syndrome. J Rheumatol 19:508\u2013512","journal-title":"J Rheumatol"},{"key":"4888_CR18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.semarthrit.2006.09.003","volume":"36","author":"R Cervera","year":"2007","unstructured":"Cervera R, Espinosa G, Cordero A, Oltra MR, Unzurrunzaga A, Rossi\u00f1ol T, Plaza J, Bucciarelli S, Ramos-Casals M, Ingelmo M, Asherson RA, Font J, Catastrophic Antiphospholipid Syndrome (CAPS) Registry Project Group (2007) Intestinal involvement secondary to the antiphospholipid syndrome (APS): clinical and immunologic characteristics of 97 patients: comparison of classic and catastrophic APS. Semin Arthritis Rheum 36:287\u2013296","journal-title":"Semin Arthritis Rheum"},{"key":"4888_CR19","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s10157-005-0387-2","volume":"9","author":"H Yotsueda","year":"2005","unstructured":"Yotsueda H, Tsuruya K, Tokumoto M, Hirakata H, Iida M (2005) Catastrophic antiphospholipid antibody syndrome following initiation of hemodialysis. Clin Exp Nephrol 9:335\u2013339","journal-title":"Clin Exp Nephrol"},{"key":"4888_CR20","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s10067-004-1017-1","volume":"24","author":"M Koenig","year":"2005","unstructured":"Koenig M, Roy M, Baccot S, Cuilleron M, de Filippis JP, Cath\u00e9bras P (2005) Thrombotic microangiopathy with liver, gut, and bone infarction (catastrophic antiphospholipid syndrome) associated with HELLP syndrome. Clin Rheumatol 24:166\u2013168","journal-title":"Clin Rheumatol"},{"key":"4888_CR21","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s00296-003-0296-1","volume":"23","author":"JS Jurgensen","year":"2003","unstructured":"Jurgensen JS, Kettritz R, Schneider W, Koop H, Hildebrand TS, Frei U, Eckardt KU (2003) Catastrophic antiphospholipid syndrome masquerading as ischaemic colitis. Rheumatol Int 23:204\u2013206","journal-title":"Rheumatol Int"},{"key":"4888_CR22","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1097\/01.meg.0000230085.45674.84","volume":"18","author":"C Bachmeyer","year":"2006","unstructured":"Bachmeyer C, Barrier A, Frazier A, Fulgencio JP, Lecomte I, Grateau G, Callard P (2006) Diffuse large and small bowel necrosis in catastrophic antiphospholipid syndrome. Eur J Gastroenterol Hepatol 18:1011\u20131014","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"4888_CR23","doi-asserted-by":"publisher","first-page":"178","DOI":"10.2350\/09-06-0667-OA.1","volume":"13","author":"A Gru","year":"2010","unstructured":"Gru A, Dehner LP (2010) Catastrophic antiphospholipid syndrome in a child with trisomy 21. An acquired thrombopathy with a discussion of thrombopathies in childhood. Pediatr Dev Pathol 13:178\u2013183","journal-title":"Pediatr Dev Pathol"},{"key":"4888_CR24","doi-asserted-by":"publisher","first-page":"e214","DOI":"10.1016\/j.jaad.2012.03.010","volume":"67","author":"LR Townsend","year":"2012","unstructured":"Townsend LR, Cotton JP, Altman DA, Gildenberg SR (2012) Catastrophic antiphospholipid syndrome. J Am Acad Dermatol 67:e214\u2013e216","journal-title":"J Am Acad Dermatol"},{"key":"4888_CR25","first-page":"4875","volume":"12","author":"R A\u00f1\u00f3n","year":"2006","unstructured":"A\u00f1\u00f3n R, Bosc\u00e1 MM, Sanchiz V, Tosca J, Almela P, Amor\u00f3s C, Benages A (2006) Factors predicting poor prognosis in ischemic colitis. World J Gastroenterol 12:4875\u20134878","journal-title":"World J Gastroenterol"},{"key":"4888_CR26","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s11926-018-0773-x","volume":"20","author":"C Mendoza-Pinto","year":"2018","unstructured":"Mendoza-Pinto C, Garc\u00eda-Carrasco M, Cervera R (2018) Role of infectious diseases in the antiphospholipid syndrome (including its catastrophic variant). Curr Rheumatol Rep 20:62","journal-title":"Curr Rheumatol Rep"},{"key":"4888_CR27","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1182\/blood-2005-03-1319","volume":"106","author":"F Fischetti","year":"2005","unstructured":"Fischetti F, Durigutto P, Pellis V, Debeus A, Macor P, Bulla R, Bossi F, Ziller F, Sblattero D, Meroni P, Tedesco F (2005) Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor. Blood 106:2340\u20132346","journal-title":"Blood"},{"key":"4888_CR28","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1093\/rheumatology\/kew040","volume":"55","author":"A Barratt-Due","year":"2016","unstructured":"Barratt-Due A, Floisand Y, Orrem HL, Kvam AK, Holme PA, Bergseth G, Tj\u00f8nnfjord GE, Mollnes TE (2016) Complement activation is a crucial pathogenic factor in catastrophic antiphospholipid syndrome. Rheumatology (Oxford) 55:1337\u20131339","journal-title":"Rheumatology (Oxford)"},{"key":"4888_CR29","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.autrev.2019.03.015","volume":"18","author":"A Ruffatti","year":"2019","unstructured":"Ruffatti A, Tarzia V, Fedrigo M, Calligaro A, Favaro M, Macor P, Tison T, Cucchini U, Cosmi E, Tedesco F, Angelini A, Gerosa G (2019) Evidence of complement activation in the thrombotic small vessels of a patient with catastrophic antiphospholipid syndrome treated with eculizumab. Autoimmun Rev 18:561\u2013563","journal-title":"Autoimmun Rev"},{"key":"4888_CR30","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3324\/haematol.2018.198119","volume":"104","author":"P Durigutto","year":"2019","unstructured":"Durigutto P, Grossi C, Borghi MO, Macor P, Pregnolato F, Raschi E, Myers MP, de Groot PG, Meroni PL, Tedesco F (2019) New insight into antiphospholipid syndrome: antibodies to \u03b22glycoprotein I-domain 5 fail to induce thrombi in rats. Haematologica 104:819\u2013826","journal-title":"Haematologica"},{"key":"4888_CR31","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1097\/00000658-199904000-00005","volume":"229","author":"MR Grotz","year":"1999","unstructured":"Grotz MR, Deitch EA, Ding J, Xu D, Huang Q, Regel G (1999) Intestinal cytokine response after gut ischemia: role of gut barrier failure. Ann Surg 229:478\u2013486","journal-title":"Ann Surg"},{"key":"4888_CR32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0002-9610(05)80611-7","volume":"159","author":"J Redan","year":"1990","unstructured":"Redan J, Rush B, Lysz T, Smith S, Machiedo G (1990) Organ distribution of gut-derived bacteria caused by bowel manipulation or ischemia. Am J Surg 159:85\u201390","journal-title":"Am J Surg"},{"key":"4888_CR33","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/0022-4804(89)90059-0","volume":"46","author":"AJ Plonka","year":"1989","unstructured":"Plonka AJ, Schentag JJ, Messinger S, Adelman MH, Francis KL, Williams JS (1989) Effects of enteral and intravenous antimicrobial treatment on survival following intestinal ischemia in rats. J Surg Res 46:216\u2013220","journal-title":"J Surg Res"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04888-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-019-04888-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04888-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T00:41:45Z","timestamp":1608165705000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-019-04888-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,18]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["4888"],"URL":"https:\/\/doi.org\/10.1007\/s10067-019-04888-5","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,18]]},"assertion":[{"value":"24 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All procedures performed in the study were in accordance with the ethical standards of the Institutional Review Board for observational studies and the Audit Committee of the University Hospital of Padua (reference number: 6894) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The patient gave informed consent for publication of this case study\/report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}